VR Logo

Unrated

SBI Healthcare Opportunities Fund - Direct Plan


1 Lakh

Investment Grown to
₹ 1.79 Lakh

₹ 10000

Monthly SIP Grown to
₹ 5.89 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund 7.46 1.33 4.54 13.12 5.21 18.48 58.35 21.53 10.02 16.05 --
S&P BSE Healthcare TRI 8.08 1.22 4.43 13.86 7.08 18.58 57.75 20.01 9.16 12.78 --
Equity: Sectoral-Pharma 6.76 1.10 4.05 12.69 5.78 17.96 55.93 23.38 12.82 16.49 --
Rank within category 3 2 2 4 7 4 4 4 4 2 --
Number of funds in category 9 9 9 9 9 9 9 4 4 3 0

As on 20-Apr-2021

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
SBI Healthcare Opportunities Fund - Direct Plan  | Invest Online
Unrated
Jan-13 58.35 21.53 10.02 1.11 1,564
Nippon India Pharma Fund - Direct Plan
Unrated
Jan-13 56.17 25.42 16.33 0.82 4,261
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund - Direct Plan  | Invest Now
Unrated
Jul-18 59.79 -- -- 1.45 2,214
Mirae Asset Healthcare Fund - Direct Plan  | Invest Online
Unrated
Jul-18 59.54 -- -- 0.50 1,269
DSP Healthcare Fund - Direct Plan  | Invest Online
Unrated
Nov-18 69.23 -- -- 0.73 1,110

Best & Worst Performance

Best Performance Worst Performance
Return (%) Period Return (%) Period
Week 19.12 01-Apr-2020 - 09-Apr-2020 -12.54 11-Mar-2020 - 18-Mar-2020
Month 31.74 23-Mar-2020 - 22-Apr-2020 -22.73 20-Feb-2020 - 23-Mar-2020
Quarter 44.79 23-Mar-2020 - 22-Jun-2020 -14.82 26-Sep-2016 - 26-Dec-2016
Year 91.69 07-Apr-2014 - 08-Apr-2015 -18.21 27-Sep-2016 - 27-Sep-2017

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund 20.30 21.50 0.74 1.35 0.89 2.55
S&P BSE Healthcare TRI 19.45 23.41 0.64 1.40 -- --
Equity: Sectoral-Pharma 21.90 20.97 0.83 1.71 0.87 4.39
Rank within category 4 3 4 4 3 4
Number of funds in category 4 4 4 4 4 4

The Risk Measures have been calculated using calendar month returns for the last three years.

As on 31-Mar-2021

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 20
Top 10 Stocks (%) 73.80
Top 5 Stocks (%) 49.00
Top 3 Sectors (%) 99.06
Portfolio P/B Ratio 4.13
Portfolio P/E Ratio 30.93

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 35,654 39,502
Giant (%) 10.84 11.45
Large (%) 50.28 50.56
Mid (%) 22.25 28.47
Small (%) 16.63 9.52
Tiny (%) -- 0.05

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
equal Sun Pharmaceutical Inds. Healthcare 64.23 14.48 4.95 10.70
equal Dr. Reddy's Lab Healthcare 39.40 10.86 0.00 10.11
equal Lupin Healthcare 43.17 10.14 0.00 9.79
equal Cipla Healthcare 34.22 10.25 2.05 9.38
equal Aurobindo Pharma Healthcare 10.75 11.32 0.00 9.02
equal Divi's Laboratories Healthcare 53.70 10.72 5.42 8.34
equal Alkem Laboratories Healthcare 21.35 6.48 0.00 4.43
equal Narayana Hrudayalaya Healthcare -- 4.60 0.00 4.15
equal Strides Pharma Science Healthcare 438.14 9.29 3.40 4.05
equal Abbott India Healthcare 48.64 7.11 0.00 3.83
equal Ajanta Pharma Healthcare 24.97 4.64 0.00 3.44
equal Sequent Scientific Healthcare 65.32 3.44 1.36 3.08
new Max Healthcare Institute Healthcare 238.29 3.03 0.00 3.03
down Apollo Hospitals Healthcare 233.11 3.59 0.00 2.97
equal JB Chemicals & Pharma Healthcare 25.10 2.89 0.00 2.89
equal Solara Active Pharma Sciences Healthcare 28.58 2.87 0.40 2.67
down Gufic Biosciences Healthcare 32.35 5.17 1.75 2.46
equal Gland Pharma Healthcare 55.94 3.16 0.00 2.22
equal Natco Pharma Healthcare 33.89 3.53 0.00 2.11
equal Shreno Construction -- 0.68 0.00 0.39

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Mar-2021

Fund Manager

— Tanmaya Desai since 01-Jan-2013

Education: Mr. Desai is a B.E. (Electronics), MBA (Finance) and CFA (Level III).

Experience: Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.

Interviews:


1.33%

Change from previous, NAV as on 20-Apr-2021

Growth: ₹ 230.5829

IDCW: ₹ 160.2042


Investment Strategy

The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

Investment Details

Minimum Investment (₹) 5,000
Minimum Addl Investment (₹) 1,000
Minimum SIP Investment (₹) 500
Minimum No of Cheques 12
Minimum Withdrawal (₹) 500
Minimum Balance (₹) 1,000
Lock-in Period Not Applicable
Exit Load 0.5% for redemption within 15 days

Basic Details

Fund House: SBI Mutual Fund
Launch Date: 01-Jan-2013
Return Since Launch: 17.56%
Benchmark: S&P BSE Healthcare TRI
Riskometer: Very High
Type: Open-ended
Assets: ₹ 1,564 Cr (As on 31-Mar-2021)
Expense: 1.11% (As on 31-Mar-2021)
Risk Grade: --
Return Grade: --
Turnover: 52.00%

Most Recent Dividends

Plan Record Date Dividend (₹ / Unit)  
IDCW16-Mar-201816.4000

Contact Information

AMC: SBI Funds Management Ltd

Address: 9th Floor-Crescenzo, C-38 & 39- G Block, Bandra-Kurla Complex, Bandra (East) Mumbai - 400051

Phone: 022-61793000 / 1800-425-5425

Fax: 022-22189663

Email: [email protected]

Website: http://www.sbimf.com

Registrar & Transfer Agent: Computer Age Management Services Ltd.

Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002

Phone: 1800-3010-6767 / 1800-419-7676

Fax: 044-30407101

Email: [email protected]

Website: www.camsonline.com

Upcoming Video

Investors' Hangout

How to optimise returns with measured risk

DateFriday, 23-Apr-2021
Time12:30 PM - 01:00 PM